<bill session="117" type="h" number="5769" updated="2022-12-30T07:33:59Z">
  <state datetime="2021-10-28">REFERRED</state>
  <status>
    <introduced datetime="2021-10-28"/>
  </status>
  <introduced datetime="2021-10-28"/>
  <titles>
    <title type="display">Access to Breast Cancer Diagnosis Act of 2021</title>
    <title type="short" as="introduced">Access to Breast Cancer Diagnosis Act of 2021</title>
    <title type="official" as="introduced">To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements or treatment limitations with respect to diagnostic examinations for breast cancer that are less favorable than such requirements with respect to screening examinations for breast cancer.</title>
  </titles>
  <sponsor bioguide_id="D000624"/>
  <cosponsors>
    <cosponsor bioguide_id="A000371" joined="2022-04-01"/>
    <cosponsor bioguide_id="A000376" joined="2021-10-28"/>
    <cosponsor bioguide_id="A000148" joined="2022-10-25"/>
    <cosponsor bioguide_id="B001300" joined="2022-02-25"/>
    <cosponsor bioguide_id="B001303" joined="2022-02-25"/>
    <cosponsor bioguide_id="B001295" joined="2022-09-13"/>
    <cosponsor bioguide_id="B001248" joined="2022-08-12"/>
    <cosponsor bioguide_id="B001251" joined="2022-03-30"/>
    <cosponsor bioguide_id="C001068" joined="2022-05-10"/>
    <cosponsor bioguide_id="C001053" joined="2021-10-28"/>
    <cosponsor bioguide_id="C001078" joined="2022-05-18"/>
    <cosponsor bioguide_id="C000754" joined="2022-02-18"/>
    <cosponsor bioguide_id="C001119" joined="2022-05-18"/>
    <cosponsor bioguide_id="D000631" joined="2022-07-21"/>
    <cosponsor bioguide_id="D000399" joined="2021-11-15"/>
    <cosponsor bioguide_id="F000466" joined="2021-10-28"/>
    <cosponsor bioguide_id="F000468" joined="2022-03-11"/>
    <cosponsor bioguide_id="G000551" joined="2022-04-28"/>
    <cosponsor bioguide_id="H001085" joined="2022-04-26"/>
    <cosponsor bioguide_id="H001067" joined="2022-03-16"/>
    <cosponsor bioguide_id="J000306" joined="2022-05-06"/>
    <cosponsor bioguide_id="K000396" joined="2022-10-31"/>
    <cosponsor bioguide_id="K000385" joined="2022-07-14"/>
    <cosponsor bioguide_id="K000381" joined="2022-03-17"/>
    <cosponsor bioguide_id="K000394" joined="2021-12-09"/>
    <cosponsor bioguide_id="K000397" joined="2022-04-11"/>
    <cosponsor bioguide_id="K000368" joined="2022-05-19"/>
    <cosponsor bioguide_id="L000491" joined="2021-12-01"/>
    <cosponsor bioguide_id="L000591" joined="2022-01-06"/>
    <cosponsor bioguide_id="M001203" joined="2022-05-13"/>
    <cosponsor bioguide_id="M000871" joined="2022-06-16"/>
    <cosponsor bioguide_id="M001208" joined="2021-11-15"/>
    <cosponsor bioguide_id="M001188" joined="2022-07-21"/>
    <cosponsor bioguide_id="M001160" joined="2022-06-03"/>
    <cosponsor bioguide_id="M001206" joined="2022-03-11"/>
    <cosponsor bioguide_id="M001190" joined="2022-03-24"/>
    <cosponsor bioguide_id="N000191" joined="2022-02-08"/>
    <cosponsor bioguide_id="N000192" joined="2022-05-10"/>
    <cosponsor bioguide_id="P000608" joined="2022-09-13"/>
    <cosponsor bioguide_id="P000617" joined="2021-11-15"/>
    <cosponsor bioguide_id="R000606" joined="2022-05-27"/>
    <cosponsor bioguide_id="S001200" joined="2022-02-01"/>
    <cosponsor bioguide_id="T000468" joined="2022-05-27"/>
    <cosponsor bioguide_id="T000483" joined="2022-05-03"/>
    <cosponsor bioguide_id="V000133" joined="2022-05-18"/>
    <cosponsor bioguide_id="V000134" joined="2022-02-04"/>
    <cosponsor bioguide_id="W000797" joined="2021-10-28"/>
    <cosponsor bioguide_id="W000826" joined="2022-02-03"/>
  </cosponsors>
  <actions>
    <action datetime="2021-10-28">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-10-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2021-10-29">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="s" number="1067" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2021-11-24T19:52:40Z" status="Introduced in House">Access to Breast Cancer Diagnosis Act of 2021

This bill prohibits private health insurance plans from imposing higher cost-sharing requirements on breast cancer diagnostic examinations than initial breast cancer screening examinations. Diagnostic examinations are generally required after an initial screening detects an abnormality and typically require additional mammogram images (e.g., x-rays).</summary>
</bill>
